Red Sox expect Justin Slaten to miss rest of 2026 after PRP injection for flexor issue

What happened

Justin Slaten is not expected to pitch again in 2026. Interim manager Chad Tracy told reporters — with Tim Healey of The Boston Globe and Perla Paredes of MLB.com relaying the remarks — that the right-handed reliever received a platelet-rich plasma injection after being diagnosed with what Tracy described as "degenerative changes in his flexor mass." Per Anthony Franco at MLB Trade Rumors, Tracy characterized the news as "substantially different" from the initial diagnosis that landed Slaten on the injured list roughly a month ago with elbow inflammation.

There is no indication in the report of ligament damage, and no mention of surgery. But flexor injuries of this kind can sometimes precede elbow procedures, and the framing from Tracy — "substantially different news" — makes clear this is not a routine bump in a recovery timeline.

Why it matters

Slaten was not just a depth arm. Per the report, only Garrett Whitlock and Aroldis Chapman had pitched in higher-leverage situations on average for Boston this season. He and Tyron Guerrero were tied for second on the team with 17 holds apiece, trailing Whitlock's 25. That is a meaningful slice of the late-inning workload, and losing it in the final weeks of a pennant race — and potentially into October — is not a trivial subtraction.

The broader context makes the loss sting a little more. A week removed from Rafael Devers being placed on the injured list with a core muscle injury that ended his 2026 season, the Red Sox are navigating a stretch run with a roster that keeps requiring creative arithmetic. The good news, such as it is, is that Willson Contreras was activated from the injured list earlier this week after a left hamstring strain, returning for the stretch run and playoffs.

Slaten's story also carries some weight beyond the transaction wire. Per Anthony Franco at MLB Trade Rumors, he was a find in the 2023 Rule 5 draft — the kind of discovery that makes front offices feel briefly like geniuses. As a rookie he threw 55 1/3 innings of 2.93 ERA ball and struck out more than a quarter of the batters he faced, pitching his way into a setup role by season's end. The two years since have brought injuries and a modest step back in results, but he remained a trusted leverage arm. That arc — Rule 5 gem, shoulder trouble in 2025, now a flexor issue in 2026 — is the kind of thing that makes a bullpen's depth chart look deceptively thin on paper.

The numbers

Slaten's 2026 season line, per the report: 31 1/3 innings, a 4.60 ERA, and a strikeout rate of 28.5% — a personal best. The 31 1/3 frames represent a career low in innings. For context, his 2025 campaign covered 34 innings at a 4.24 ERA after he missed a couple of months with shoulder inflammation. His rookie season remains the benchmark: 55 1/3 innings, 2.93 ERA, strikeouts on more than a quarter of opponents.

The Red Sox enter Wednesday sitting at 82-69 (.543), third in the AL East and 9.5 games back in the division. Their Wild Card position is more relevant: ranked second, +5.5 relative to the cut line. They are coming off a loss, carrying a one-game losing streak into a road series at Texas.

Where the club stands

Boston is 82-69 (.543), third in the AL East, and holding the second Wild Card spot at +5.5 relative to the cut line. The upcoming schedule sends them to Globe Life Field on Wednesday and Thursday — Jake Bennett is the probable against MacKenzie Gore on Wednesday, with Sonny Gray lined up Thursday against a Texas starter to be determined — before a Friday trip to Tropicana Field to face the Tampa Bay Rays.

The bullpen picture heading into that stretch is worth mapping out. Per Anthony Franco at MLB Trade Rumors, Chapman remains an elite closer. Whitlock is among the best setup men in the league. Erik Miller, who came over from the Giants at the deadline, gives Boston a high-octane left-handed option to deploy in front of the ninth inning. Brayan Bello has found more success working out of the bullpen this year than he has as a rotation piece. Guerrero, who is reportedly expected to return from the injured list this week, has been a productive find on an offseason minor-league deal. Alec Gamboa has emerged as a middle-innings lefty option, and Greg Weissert has performed well since returning from Triple-A about a month ago.

Then there is the trio of Garrett Crochet, Tanner Houck, and Johan Oviedo, all working back from injury and potentially available in October. Per the report, only Crochet would be a lock for a 13-pitcher playoff roster even if all three are healthy. Houck, per earlier MLB Trade Rumors reporting, has been recovering from Tommy John and flexor tendon repair — a detail that gives the phrase "flexor issue" an uncomfortable resonance in this particular clubhouse right now.

What we don't know yet

The report does not include a timetable for Slaten beyond the expectation that he will not return this season. There is no mention of whether he will require surgery, only that there is no indication of ligament damage at this stage. The PRP injection is a treatment, not a resolution, and what comes next for his elbow — and for his availability in any potential postseason — remains unaddressed in the material.

Guerrero's return is described as expected "this week," but no specific date or activation has been reported.

What to watch

The practical question for Boston's October planning is how the bullpen depth holds if Crochet, Houck, and Oviedo are not all available — or not all effective — when the roster decisions come due. Per the report, Crochet is the only lock among that group, which means the back end of a playoff bullpen could look quite different depending on how the next few weeks unfold.

Closer to the immediate schedule: Guerrero's expected return from the injured list would restore one of the two arms tied for second on the team in holds, which matters in a pennant race where every high-leverage inning counts. Whether that return materializes this week, and how quickly he is trusted in tight spots, is worth tracking as Boston heads into Texas.